Form 4: Mainz Biomed Director Receives Stock Grant
Insider Transaction (Form 4)
Peter O'Rourke, a Director of Mainz Biomed N.V., received 190,840 shares of common stock on July 31, 2026.
Summary
- Grant/award: acquired 190,840 Stock Option (Right to Buy) on July 31, 2026; holds 190,840 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Peter O'Rourke — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-31 | Grant/award | Stock Option (Right to Buy) | 190,840 | — | — | 190,840 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-31 | Grant/award (190,840 shares) |
Keywords
insider transaction, Form 4, QUCY, Quantum Cyber N.V., neutral, Peter O'Rourke
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.